SV

Street Verdict

Analyst Scorecard

A record of what Vaishali Parekh said publicly, with the source. Not advice.

“Recommends buying Natco Pharma at ₹823 with a target of ₹860 and a stop loss at ₹800 for intraday trading.”

Vaishali Parekh’s track record (trackable calls only): 742 graded calls · 95% CI 30–37%

Natco PharmaBullishCalled 13 Nov 2025Graded 20 Nov 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry: ₹823, as stated.

Target ₹860, stop ₹800, as stated.

Window: 30 days, the time frame the call states ("intraday").

The target ₹860 was reached on a close before the stop ₹800. Hit.

The grader’s working: R3 TRADE_SETUP: entered ₹823 on 2025-11-14 (stated entry ₹823, LEVEL_CMP entry, filled); target ₹860 reached at close ₹869.3 on 2025-11-20. Window 30 days — rule H1: the quote says "intraday" (a one-day claim, judged over 30 days; MISS if neither level is reached).

How it played out

How this is worked out
Target or stop first
The target was reached on a close before the stop was.
Time to target
The target was reached on a close 4 trading sessions (6 calendar days) after the entry.
Worst close against it
The closing price went as far as 1.26% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Natco Pharma since this call

1-year tracking window
Read the original articleSee Vaishali Parekh’s full track record